Comparison of headache and facial pain prevalence and phenotype in upper respiratory tract infections of differing origins — a cross-sectional study
, 2
Abstract
Aim of study. This study aimed to compare headache and facial pain prevalence and headache phenotype among people with common upper respiratory tract infections (URTIs).
Clinical rationale for study. Headache is a common symptom in viral URTI, but its phenotyping has so far been limited to coronavirus disease 2019 (COVID-19) and influenza. Additionally, the prevalence of facial pain in URTIs has only rarely been discussed in scientific publications.
Material and methods. Patients with acute URTI symptoms were evaluated for headache phenotype using a semi-structured questionnaire. Antigen swab tests were performed in all participants.
Results. The analysis included 276 URTI/APVRS (acute post-viral rhinosinusitis) episodes in 223 patients (136 women, 60.1%) aged 18–73 [mean 41.3 / median (25th, 75th) 40 / standard deviation 15.1]. Participants were diagnosed with: COVID-19 — 107/276 (38.8%); ‘common cold’ — 103/276 (37.3%); influenza — 36/276 (13.0%); or APVRS — 30/276 (10.9%). Headache was present in 183/276 (66.3%) and URTIs and facial pain in 107/276 (38.8%). Predictors of headache in URTIs included sinonasal symptoms (odds ratio (OR) 10.70, p < 0.001) and fever (OR 2.9, p = 0.004). Headache more often (p = 0.030) had a migraine-like phenotype in COVID-19 (27.4% (20/73) vs. 9.1% (10/110) and tension-type headache (TTH)-like phenotype in ‘common cold’ (75.4%, 49/64 vs. 61.3%, 73/119). Previous COVID-19 immunisation (vaccination or infection) was associated (p = 0.004) with a lower prevalence of migraine-like headache [6.3% (1/16) vs. 32.8% (19/58)].
Conclusions and clinical implications. Headache and facial pain are prevalent during URTIs, and are associated with general and sinonasal immune response rather than virus type. Headache phenotype may depend on the causative microorganism, but it can evolve in response to previous immunisation. Our study supports vaccination against COVID-19, as people with prior immunisation are probably less likely to experience migraine-like headache.
Keywords: migrainetension-type headacheCOVID-19SARS-CoV-2influenzacommon cold
References
- Straburzyński M, Kuca-Warnawin E, Waliszewska-Prosół M. COVID-19-related headache and innate immune response - a narrative review. Neurol Neurochir Pol. 2023; 57(1): 43–52.
- Czarnowska A, Zajkowska J, Kułakowska A. Impact of SARS-CoV-2 on the nervous system. Neurol Neurochir Pol. 2023; 57(1): 26–35.
- Caronna E, Ballvé A, Llauradó A, et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40(13): 1410–1421.
- Mitsikostas DDD, Caronna E, De Tommaso M, et al. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. Eur J Neurol. 2024; 31(6): e16251.
- Straburzyński M, Nowaczewska M, Budrewicz S, et al. COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Cephalalgia. 2022; 42(3): 218–228.
- García-Azorín D, Sierra Á, Trigo J, et al. Frequency and phenotype of headache in covid-19: a study of 2194 patients. Sci Rep. 2021; 11(1): 14674.
- Mäkelä MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998; 36(2): 539–542.
- Geismar C, Nguyen V, Fragaszy E, et al. Symptom profiles of community cases infected by influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern. Sci Rep. 2023; 13(1): 12511.
- Zeng ZQ, Chen DH, Tan WP, et al. Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China. Eur J Clin Microbiol Infect Dis. 2018; 37(2): 363–369.
- Liu WK, Liu Q, Chen DH, et al. Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis. 2013; 13: 28.
- Widmer K, Griffin MR, Zhu Y, et al. Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respir Viruses. 2014; 8(3): 347–352.
- Casado I, Domínguez A, Toledo D, et al. Project Pi12/2079 Working Group. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Expert Rev Vaccines. 2016; 15(3): 425–432.
- López JT, García-Azorín D, Planchuelo-Gómez Á, et al. Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020; 40(13): 1432–1442.
- García-Azorín D, Santana-López L, Lozano-Alonso JE, et al. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection. Cephalalgia. 2023; 43(11): 3331024231212900.
- Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, et al. Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022; 42(8): 804–809.
- Torres M, Serra-Sutton V, Soriano JB, et al. Consensus on post COVID in the Spanish national health system: Results of the CIBERPOSTCOVID eDelphi study. J Infect Public Health. 2023; 16(11): 1784–1792.
- González-Herazo MA, Silva-Muñoz DC, Guevara-Martínez PA, et al. Post-COVID 19 Neurological Syndrome: a fresh challenge in neurological management. Neurol Neurochir Pol. 2021; 55(4): 413–414.
- Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021; 11(3): 213–739.
- Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58(Suppl S29): 1–464.
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9): 629–808.
- Sample Size Calculator. https://clincalc.com/stats/samplesize.aspx (12.10.2024).
- Karadaş Ö, Öztürk B, Sonkaya AR, et al. Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6. Neurol Sci. 2021; 42(5): 1665–1673.
- Waliszewska-Prosół M, Budrewicz S. The unusual course of a migraine attack during COVID-19 infection - Case studies of three patients. J Infect Public Health. 2021; 14(7): 903–905.
- Gromadziński L, Żechowicz M, Moczulska B, et al. Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 Infection. J Clin Med. 2022; 12(1).
- Martynowicz H, Jodkowska A, Poręba R, et al. Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review. Dent Med Probl. 2021; 58(1): 115–121.
- Saki M, Shadmanpour M, Najafi HZ. Are individuals with orofacial pain more prone to psychological distress during the COVID-19 pandemic? Dent Med Probl. 2021; 58(1): 17–25.
- International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020; 40(2): 129–221.
- García-Azorín D, Santana-López L, Lozano-Alonso JE, et al. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010-2020 surveillance-based study. J Headache Pain. 2024; 25(1): 18.
- Straburzyński M, Waliszewska-Prosół M, Nowaczewska M, et al. Prevalence of cranial autonomic symptoms in frequent episodic tension-type headache: A post hoc analysis of the cross-sectional Migraine in Poland study. Dent Med Probl. 2024; 61(4): 489–493.
- Melbye H, Joensen L, Risør MB, et al. Symptoms of respiratory tract infection and associated care-seeking in subjects with and without obstructive lung disease; the Tromsø Study: Tromsø 6. BMC Pulm Med. 2012; 12: 51.
